lobenzarit
Small moleculeexperimental
Lobenzarit (INN) is a drug used in the treatment of arthritis. It is an immunomodulator. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 30, 2018 (NCT03660059)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- CyclooxygenaseINHIBITOR
Cyclooxygenase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
O=C(O)c1ccccc1Nc1cc(Cl)ccc1C(=O)O- Mol. weight
- 291.69 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLobenzarit ↗
- ChEMBLCHEMBL1986706 ↗
Also known as
- lobenzarit
- lobenzarit
- lobenzarit
- lobenzarit
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03660059 | Phase 3 | Sep 30, 2018 | Astellas |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1